P. Friis

Advance care planning discussions with geriatric patients.

R. Førde, P. Friis, 2015, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

Dalteparin in Acute Ischemic Cerebrovascular Disease: A Safety Study

U. Abildgaard, T. Dahl, P. Friis, 1997 .

Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial

P. Deyn, D. Leys, J. Orgogozo, 2001, The Lancet.

Relationship between outcome and baseline blood pressure and other haemodynamic measures in acute ischaemic stroke: data from the TAIST trial

D. Leys, G. Boysen, P. Bath, 2006, Journal of hypertension.

Stroke severity, early recovery and outcome are each related with clinical classification of stroke: Data from the ‘Tinzaparin in Acute Ischaemic Stroke Trial’ (TAIST)

P. Deyn, D. Leys, E. Ringelstein, 2007, Journal of the Neurological Sciences.

Hemostatic activation in acute ischemic stroke.

E. Berge, P. Sandset, P. Sandset, 2001, Thrombosis research.

Significant variation in mortality and functional outcome after acute ischaemic stroke between western countries: data from the tinzaparin in acute ischaemic stroke trial (TAIST)

D. Leys, P. Sørensen, G. Boysen, 2005, Journal of Neurology, Neurosurgery & Psychiatry.

Early recovery and functional outcome are related with causal stroke subtype: data from the tinzaparin in acute ischemic stroke trial.

D. Leys, E. Ringelstein, G. Boysen, 2007, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.